NASDAQ: DRDBRoman Dbdr Acquisition Corp II Stock
$10.52-0.01 (-0.09%)
Updated Jun 18, 2026
DRDB Price
$10.52
Fair Value Price
N/A
Market Cap
$322.61M
52 Week Low
$10.23
52 Week High
$10.56
P/E
61.88x
P/B
-121.12x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
$5.29M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
-1.08
Operating Cash Flow
-$1M
Beta
0.01
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
DRDB Overview
Roman DBDR Acquisition Corp. II (DRDB) functions as a special purpose acquisition company (SPAC), formed with the explicit goal of identifying and executing a business combination with another entity. This could involve various forms of strategic integration, such as a merger, an acquisition of assets or shares, or a corporate reorganization. The firm was established on July 25, 2024, and its principal headquarters are situated in Boca Raton, Florida.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine DRDB's potential to beat the market
- DRDB doesn't meet the minimum data requirements for our proprietary Zen Ratings model. Learn more about Zen Ratings.
Zen Rating Component Grades
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Shell Company
Industry Rating
F
DRDB
RankedUnranked of 30
RankedUnranked of 30
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $10.80 | C | |
| $11.14 | C | |
| $12.57 | C |
Be the first to know about important DRDB news, forecast changes, insider trades & much more!
DRDB News
Overview
Due Diligence Score
–
Industry Average (6)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how DRDB scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
DRDB is poor value based on its earnings relative to its share price (61.88x), compared to the US market average (9.47x)
P/E vs Market Valuation
DRDB is poor value based on its earnings relative to its share price (61.88x), compared to the US Shell Companies industry average (15.56x)
P/E vs Industry Valuation
DRDB's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
There are 30 more DRDB due diligence checks available for Premium users.
Valuation
DRDB price to earnings (PE)
For valuing profitable companies with steady earnings
Company
61.88x
Industry
15.56x
Market
9.47x
DRDB is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
DRDB is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation
DRDB price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
-121.12x
Industry
78.31x
DRDB's financial health
Profit margin
Revenue
$0.0
Net Income
-$235.1k
Profit Margin
0%
DRDB's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
Assets to liabilities
Assets
$243.1M
Liabilities
$2.9M
Debt to equity
-1.08
DRDB's short-term liabilities ($2.40M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
DRDB's long-term liabilities ($480.00k) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
DRDB's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
DRDB's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$409.5k
Investing
$0.0
Financing
$280.0k
DRDB's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
DRDB vs Shell Company Stocks
Roman Dbdr Acquisition II Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.